Version Française
Logo retour accueil

Last news

  • Collaborative agreement with Pfizer

    IntegraGen announces Collaborative Agreement with Pfizer to evaluate IntegraGen's proprietary Hepatocellular Carcinoma Molecular signature.

    Read more

  • IntegraGen and Gustave Roussy Announce High-Throughput Sequencing Unit

    IntegraGen and Gustave Roussy announce the set-up of a High-Throughput Oncology Clinical Sequencing Unit.

    Read more


IntegraGen's mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests for autism and oncology based on these discoveries. The company also strives to be a leader in providing cutting edge genomic services to academic researchers and life sciences companies based on it's technological expertise and scientific know how.

Autism Oncology Services
Disclaimers - Mentions légales - Crédits